| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/16/2023 | 21.11% | Morgan Stanley | $66 → $65 | Maintains | Equal-Weight |
| 08/17/2023 | 43.47% | Jefferies | $73 → $77 | Maintains | Buy |
| 08/17/2023 | 52.79% | UBS | $76 → $82 | Maintains | Buy |
| 08/17/2023 | 41.61% | Barclays | $74 → $76 | Maintains | Overweight |
| 08/17/2023 | 39.74% | Stephens & Co. | $68 → $75 | Maintains | Overweight |
| 08/16/2023 | 26.7% | Stephens & Co. | → $68 | Reiterates | Overweight → Overweight |
| 07/17/2023 | 22.97% | Morgan Stanley | $66 → $66 | Reiterates | Equal-Weight → Equal-Weight |
| 06/20/2023 | 22.97% | Morgan Stanley | $74 → $66 | Downgrades | Overweight → Equal-Weight |
| 05/12/2023 | 49.06% | Truist Securities | $75 → $80 | Maintains | Buy |
| 05/11/2023 | 49.06% | Credit Suisse | $76 → $80 | Maintains | Outperform |
| 02/24/2023 | 26.7% | Stephens & Co. | → $68 | Reiterates | → Overweight |
| 02/09/2023 | 41.61% | UBS | $72 → $76 | Maintains | Buy |
| 02/09/2023 | 26.7% | Stephens & Co. | → $68 | Reiterates | → Overweight |
| 02/08/2023 | 26.7% | Stephens & Co. | → $68 | Reiterates | → Overweight |
| 01/18/2023 | 37.88% | Morgan Stanley | $67 → $74 | Maintains | Overweight |
| 01/13/2023 | 26.7% | Stephens & Co. | → $68 | Reiterates | → Overweight |
| 01/12/2023 | 39.74% | Truist Securities | $72 → $75 | Maintains | Buy |
| 01/06/2023 | 26.7% | Stephens & Co. | $60 → $68 | Maintains | Overweight |
| 01/05/2023 | 37.88% | Barclays | $68 → $74 | Maintains | Overweight |
| 01/04/2023 | 34.15% | Wells Fargo | $66 → $72 | Maintains | Overweight |
| 11/14/2022 | 34.15% | Deutsche Bank | $60 → $72 | Maintains | Buy |
| 11/10/2022 | 45.33% | BMO Capital | $70 → $78 | Maintains | Outperform |
| 11/10/2022 | 24.84% | Morgan Stanley | $65 → $67 | Maintains | Overweight |
| 11/10/2022 | 34.15% | Credit Suisse | $70 → $72 | Maintains | Outperform |
| 10/20/2022 | 8.07% | Barclays | $62 → $58 | Maintains | Overweight |
| 09/23/2022 | 11.79% | Stephens & Co. | → $60 | Initiates Coverage On | → Overweight |
| 08/19/2022 | 30.43% | BMO Capital | $61 → $70 | Maintains | Outperform |
| 08/18/2022 | 11.79% | Deutsche Bank | $58 → $60 | Maintains | Buy |
| 08/18/2022 | 24.84% | Truist Securities | $62 → $67 | Maintains | Buy |
| 08/18/2022 | 19.25% | Piper Sandler | $60 → $64 | Maintains | Overweight |
| 08/18/2022 | 15.52% | Barclays | $58 → $62 | Maintains | Overweight |
| 06/30/2022 | 8.07% | Barclays | $55 → $58 | Maintains | Overweight |
| 06/09/2022 | 2.48% | Barclays | $62 → $55 | Maintains | Overweight |
| 05/18/2022 | 32.29% | Berenberg | → $71 | Initiates Coverage On | → Buy |
| 05/13/2022 | 8.07% | Deutsche Bank | $62 → $58 | Maintains | Buy |
| 05/12/2022 | 15.52% | Barclays | $65 → $62 | Maintains | Overweight |
| 03/18/2022 | 15.52% | Deutsche Bank | → $62 | Initiates Coverage On | → Buy |
| 03/11/2022 | 11.79% | CL King | → $60 | Initiates Coverage On | → Buy |
| 02/10/2022 | 21.11% | Morgan Stanley | $62 → $65 | Maintains | Overweight |
| 02/01/2022 | 13.66% | Truist Securities | → $61 | Initiates Coverage On | → Buy |
| 12/15/2021 | 6.2% | Barclays | $58 → $57 | Maintains | Overweight |
| 11/11/2021 | 30.43% | Credit Suisse | $68 → $70 | Maintains | Outperform |
| 09/29/2021 | 11.79% | Barclays | → $60 | Reinstates | → Overweight |
| 09/17/2021 | 13.66% | BMO Capital | $63 → $61 | Maintains | Outperform |
| 08/20/2021 | 26.7% | Credit Suisse | $72 → $68 | Maintains | Outperform |
| 08/20/2021 | — | BTIG | Downgrades | Buy → Neutral | |
| 07/29/2021 | 15.52% | UBS | → $62 | Initiates Coverage On | → Buy |
| 04/12/2021 | 15.52% | Morgan Stanley | $58 → $62 | Maintains | Overweight |
| 04/09/2021 | 19.25% | Piper Sandler | → $64 | Initiates Coverage On | → Overweight |
| 02/04/2021 | 11.79% | Credit Suisse | $56 → $60 | Maintains | Outperform |
| 02/04/2021 | 8.07% | Morgan Stanley | $54 → $58 | Maintains | Overweight |
| 01/27/2021 | 15.52% | Wells Fargo | $56 → $62 | Maintains | Overweight |
| 01/19/2021 | 0.61% | Morgan Stanley | $47 → $54 | Maintains | Overweight |
| 01/06/2021 | 11.79% | Barclays | → $60 | Upgrades | Equal-Weight → Overweight |
| 11/10/2020 | -3.11% | BMO Capital | → $52 | Upgrades | Market Perform → Outperform |
| 11/05/2020 | -16.15% | BTIG | $40 → $45 | Maintains | Buy |
| 11/05/2020 | -8.7% | Credit Suisse | $47 → $49 | Maintains | Outperform |
| 11/05/2020 | -12.43% | Morgan Stanley | $45 → $47 | Maintains | Overweight |
| 09/29/2020 | -16.15% | Morgan Stanley | → $45 | Initiates Coverage On | → Overweight |
| 09/23/2020 | -19.88% | Wolfe Research | → $43 | Initiates Coverage On | → Outperform |
| 09/21/2020 | -12.43% | Credit Suisse | $39 → $47 | Maintains | Outperform |
| 08/13/2020 | -25.47% | BTIG | $35 → $40 | Maintains | Buy |
| 07/17/2020 | -34.79% | BTIG | → $35 | Initiates Coverage On | → Buy |
| 05/05/2020 | -25.47% | Guggenheim | $58 → $40 | Maintains | Buy |
| 04/23/2020 | -45.97% | BMO Capital | $58 → $29 | Downgrades | Outperform → Market Perform |
| 04/20/2020 | -27.33% | Credit Suisse | $46 → $39 | Reinstates | → Outperform |
| 03/26/2020 | -21.74% | Jefferies | $55 → $42 | Upgrades | Hold → Buy |
| 03/16/2020 | -25.47% | Wells Fargo | $59 → $40 | Maintains | Overweight |
| 02/06/2020 | 15.52% | Buckingham Research | $58 → $62 | Maintains | Buy |
| 01/06/2020 | 8.07% | Credit Suisse | → $58 | Reinstates | → Outperform |
| 12/23/2019 | 9.93% | Wells Fargo | $53 → $59 | Maintains | Overweight |
| 11/07/2019 | -12.43% | Barclays | $44 → $47 | Maintains | Equal-Weight |
| 11/07/2019 | 8.07% | Buckingham Research | $53 → $58 | Maintains | Buy |
| 10/02/2019 | -3.11% | B of A Securities | $45 → $52 | Maintains | Buy |
| 08/15/2019 | -1.25% | Buckingham Research | $47 → $53 | Maintains | Buy |
| 07/30/2019 | -6.84% | Wells Fargo | $45 → $50 | Maintains | Outperform |
| 04/17/2019 | — | B of A Securities | Initiates Coverage On | → Buy | |
| 12/21/2018 | -25.47% | Citigroup | → $40 | Initiates Coverage On | → Buy |
| 10/23/2018 | -27.33% | Buckingham Research | → $39 | Initiates Coverage On | → Buy |
What is the target price for Performance Food Gr (PFGC)?
The latest price target for Performance Food Gr (NYSE: PFGC) was reported by Morgan Stanley on October 16, 2023. The analyst firm set a price target for $65.00 expecting PFGC to rise to within 12 months (a possible 21.11% upside). 25 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Performance Food Gr (PFGC)?
The latest analyst rating for Performance Food Gr (NYSE: PFGC) was provided by Morgan Stanley, and Performance Food Gr maintained their equal-weight rating.
When is the next analyst rating going to be posted or updated for Performance Food Gr (PFGC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Performance Food Gr, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Performance Food Gr was filed on October 16, 2023 so you should expect the next rating to be made available sometime around October 16, 2024.
Is the Analyst Rating Performance Food Gr (PFGC) correct?
While ratings are subjective and will change, the latest Performance Food Gr (PFGC) rating was a maintained with a price target of $66.00 to $65.00. The current price Performance Food Gr (PFGC) is trading at is $53.67, which is out of the analyst's predicted range.